Metabolic biotinylation of recombinant antibody by biotin ligase retained in the endoplasmic reticulum

Altman, 1996, Phenotypic analysis of antigen-specific T lymphocytes, Science, 274, 94, 10.1126/science.274.5284.94 Arnold, 2006, Metabolic biotinylation provides a unique platform for the purification and targeting of multiple AAV vector serotypes, Mol. Ther., 14, 97, 10.1016/j.ymthe.2006.02.014 Asai, 2005, A human biotin acceptor domain allows site-specific conjugation of an enzyme to an antibody-avidin fusion protein for targeted drug delivery, Biomol. Eng., 21, 145, 10.1016/j.bioeng.2004.10.001 Bayer, 1990, Protein biotinylation, Methods Enzymol., 184, 138, 10.1016/0076-6879(90)84268-L Bebbington, 1992, High-level expression of a recombinant antibody from myeloma cells using a glutamine synthetase gene as an amplifiable selectable marker, Biotechnology (NY), 10, 169, 10.1038/nbt0292-169 Beckett, 1999, A minimal peptide substrate in biotin holoenzyme synthetase-catalyzed biotinylation, Protein Sci., 8, 921, 10.1110/ps.8.4.921 Beerli, 1994, Autocrine inhibition of the epidermal growth factor receptor by intracellular expression of a single-chain antibody, Biochem. Biophys. Res. Commun., 204, 666, 10.1006/bbrc.1994.2511 Beerli, 1994, Intracellular expression of single chain antibodies reverts ErbB-2 transformation, J. Biol. Chem., 269, 23931, 10.1016/S0021-9258(19)51027-4 Campos, 2004, Rapid construction of capsid-modified adenoviral vectors through bacteriophage lambda Red recombination, Hum. Gene Ther., 15, 1125, 10.1089/hum.2004.15.1125 Carmichael, 2003, The crystal structure of an anti-CEA scFv diabody assembled from T84.66 scFvs in V(L)-to-V(H) orientation: implications for diabody flexibility, J. Mol. Biol., 326, 341, 10.1016/S0022-2836(02)01428-6 Chapman-Smith, 1999, In vivo enzymatic protein biotinylation, Biomol. Eng., 16, 119, 10.1016/S1050-3862(99)00046-7 Cronan, 1990, Biotination of proteins in vivo. A post-translational modification to label, purify, and study proteins, J. Biol. Chem., 265, 10327, 10.1016/S0021-9258(18)86949-6 Cull, 2000, Biotinylation of proteins in vivo and in vitro using small peptide tags, Methods Enzymol., 326, 430, 10.1016/S0076-6879(00)26068-0 de Boer, 2003, Efficient biotinylation and single-step purification of tagged transcription factors in mammalian cells and transgenic mice, Proc. Natl. Acad. Sci. U.S.A., 100, 7480, 10.1073/pnas.1332608100 Diamandis, 1991, The biotin–(strept)avidin system: principles and applications in biotechnology, Clin. Chem., 37, 625, 10.1093/clinchem/37.5.625 Galfre, 1981, Preparation of monoclonal antibodies: strategies and procedures, Methods Enzymol., 73, 3, 10.1016/0076-6879(81)73054-4 Holliger, 1993, “Diabodies”: small bivalent and bispecific antibody fragments, Proc. Natl. Acad. Sci. U.S.A., 90, 6444, 10.1073/pnas.90.14.6444 Hu, 1996, Minibody: a novel engineered anti-carcinoembryonic antigen antibody fragment (single-chain Fv-CH3) which exhibits rapid, high-level targeting of xenografts, Cancer Res., 56, 3055 Kenanova, 2005, Tailoring the pharmacokinetics and positron emission tomography imaging properties of anti-carcinoembryonic antigen single-chain Fv-Fc antibody fragments, Cancer Res., 65, 622, 10.1158/0008-5472.622.65.2 Kojima, 2006, Rapid hepatic cell attachment onto biodegradable polymer surfaces without toxicity using an avidin–biotin binding system, Biomaterials, 27, 4904, 10.1016/j.biomaterials.2006.05.026 Krepkiy, 2006, Bacterial expression of functional, biotinylated peripheral cannabinoid receptor CB2, Protein Expres. Purif., 49, 60, 10.1016/j.pep.2006.03.002 Kumar, 2002, Protein complexes take the bait, Nature, 415, 123, 10.1038/415123a Munro, 1987, A C-terminal signal prevents secretion of luminal ER proteins, Cell, 48, 899, 10.1016/0092-8674(87)90086-9 Nesbeth, 2006, Metabolic biotinylation of lentiviral pseudotypes for scalable paramagnetic microparticle-dependent manipulation, Mol. Ther., 13, 814, 10.1016/j.ymthe.2005.09.016 Neumaier, 1990, Cloning of the genes for T84.66, an antibody that has a high specificity and affinity for carcinoembryonic antigen, and expression of chimeric human/mouse T84.66 genes in myeloma and Chinese hamster ovary cells, Cancer Res., 50, 2128 Ohno, 1996, Cell-specific, multidrug delivery system using streptavidin-protein. A fusion protein, Biochem. Mol. Med., 58, 227, 10.1006/bmme.1996.0053 Olafsen, 2004, Covalent disulfide-linked anti-CEA diabody allows site-specific conjugation and radiolabeling for tumor targeting applications, Protein Eng. Des. Sel., 17, 21, 10.1093/protein/gzh009 Parrott, 2000, Metabolic biotinylation of recombinant proteins in mammalian cells and in mice, Mol. Ther., 1, 96, 10.1006/mthe.1999.0011 Parrott, 2001, Metabolic biotinylation of secreted and cell surface proteins from mammalian cells, Biochem. Biophys. Res. Commun., 281, 993, 10.1006/bbrc.2001.4437 Parrott, 2003, Metabolically biotinylated adenovirus for cell targeting, ligand screening, and vector purification, Mol. Ther., 8, 688, 10.1016/S1525-0016(03)00213-2 Parthasarathy, 2005, An immobilized biotin ligase: surface display of Escherichia coli BirA on Saccharomyces cerevisiae, Biotechnol. Prog., 21, 1627, 10.1021/bp050279t Reddy, 1998, Structural characterization of the entire 1.3S subunit of transcarboxylase from Propionibacterium shermanii, Protein Sci., 7, 2156, 10.1002/pro.5560071013 Saviranta, 1998, In vitro enzymatic biotinylation of recombinant fab fragments through a peptide acceptor tail, Bioconjug. Chem., 9, 725, 10.1021/bc9800217 Schatz, 1993, Use of peptide libraries to map the substrate specificity of a peptide-modifying enzyme: a 13 residue consensus peptide specifies biotinylation in Escherichia coli, Biotechnology (NY), 11, 1138, 10.1038/nbt1093-1138 Smith, 1998, A plasmid expression system for quantitative in vivo biotinylation of thioredoxin fusion proteins in Escherichia coli, Nucleic Acids Res., 26, 1414, 10.1093/nar/26.6.1414 Smith, 1999, Redirected infection of directly biotinylated recombinant adenovirus vectors through cell surface receptors and antigens, Proc. Natl. Acad. Sci. U.S.A., 96, 8855, 10.1073/pnas.96.16.8855 Tannous, 2006, Metabolic biotinylation of cell surface receptors for in vivo imaging, Nat. Methods, 3, 391, 10.1038/nmeth875 Tatsumi, 1996, Construction of biotinylated firefly luciferases using biotin acceptor peptides, Anal. Biochem., 243, 176, 10.1006/abio.1996.0498 Tirat, 2006, Evaluation of two novel tag-based labelling technologies for site-specific modification of proteins, Int. J. Biol. Macromol., 39, 66, 10.1016/j.ijbiomac.2006.01.012 Tsao, 1996, A versatile plasmid expression vector for the production of biotinylated proteins by site-specific, enzymatic modification in Escherichia coli, Gene, 169, 59, 10.1016/0378-1119(95)00762-8 Verhaegen, 2002, Bacterial expression of in vivo-biotinylated aequorin for direct application to bioluminometric hybridization assays, Anal. Biochem., 306, 314, 10.1006/abio.2002.5724 Verhaegent, 2002, Recombinant Gaussia luciferase. Overexpression, purification, and analytical application of a bioluminescent reporter for DNA hybridisation, Anal. Chem., 74, 4378, 10.1021/ac025742k Viens, 2004, Use of protein biotinylation in vivo for chromatin immunoprecipitation, Anal. Biochem., 325, 68, 10.1016/j.ab.2003.10.015 Warren, 2005, Use of an in vivo biotinylated single-chain antibody as capture reagent in an immunometric assay to decrease the incidence of interference from heterophilic antibodies, Clin. Chem., 51, 830, 10.1373/clinchem.2004.046979 Wood, 1997, Biotin enzymes, Annu. Rev. Biochem. Allied Res. India, 46, 385, 10.1146/annurev.bi.46.070177.002125 Wu, 1999, Anti-carcinoembryonic antigen (CEA) diabody for rapid tumor targeting and imaging, Tumor Target., 4, 47 Wu, 2002, Design, production, and characterization of an engineered biotin ligase (BirA) and its application for affinity purification of staphylokinase produced from Bacillus subtilis via secretion, Protein Expres. Purif., 24, 357, 10.1006/prep.2001.1583 Yang, 2004, In vivo biotinylation of the major histocompatibility complex (MHC) class II/peptide complex by coexpression of BirA enzyme for the generation of MHC class II/tetramers, Hum. Immunol., 65, 692, 10.1016/j.humimm.2004.04.001 Yazaki, 2003, Construction and characterization of minibodies for imaging and therapy of colorectal carcinomas, Methods Mol. Biol., 207, 351 Yazaki, 2001, Mammalian expression and hollow fiber bioreactor production of recombinant anti-CEA diabody and minibody for clinical applications, J. Immunol. Methods, 253, 195, 10.1016/S0022-1759(01)00388-X